Second, despite the genetic heterogeneity, T-ALL patients with NUP214-ABL1 translocation usually present with high risk factors, i.e., high white blood cell count, mediastinal mass and extramedullary manifestations [202]. This evidence concerns the gene NUP214 and acute lymphoblastic leukemia.